Insider · CIK 0001385115

Maimon Yossi

Reports to the SEC for 2 companies · CARMIEL, L3

sec.gov

Transactions

Companies

Filings

CIK

0001385115

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-19	Old Ayala, IncStock Option (right to buy)D Disposition to Issuer	Director, CFO, Secretary and Treasurer	DDisposition to Issuer	−70.5K sh	—	—	0
2023-01-19	Old Ayala, IncStock Option (right to buy)D Disposition to Issuer	Director, CFO, Secretary and Treasurer	DDisposition to Issuer	−9,460 sh	—	—	0
2023-01-19	Old Ayala, IncStock Option (right to buy)D Disposition to Issuer	Director, CFO, Secretary and Treasurer	DDisposition to Issuer	−19.2K sh	—	—	0
2023-01-19	Old Ayala, IncStock Option (right to buy)D Disposition to Issuer	Director, CFO, Secretary and Treasurer	DDisposition to Issuer	−32K sh	—	—	0
2023-01-19	Old Ayala, IncD Disposition to Issuer	Director, CFO, Secretary and Treasurer	DDisposition to Issuer	−69.9K sh	—	—	0
2022-05-16	Old Ayala, IncA Award	Director, CFO, Secretary and Treasurer	AAward	+50K sh	—	—	69,872
2022-01-03	Old Ayala, IncStock OptionA Award	Director, CFO, Secretary and Treasurer	AAward	+32K sh	—	—	31,950
2021-01-04	Old Ayala, IncA Award	Director, CFO, Secretary and Treasurer	AAward	+8,520 sh	—	—	19,872
2021-01-04	Old Ayala, IncStock OptionA Award	Director, CFO, Secretary and Treasurer	AAward	+19.2K sh	—	—	19,170
2020-05-07	Old Ayala, IncA Award	Director, CFO, Secretary and Treasurer	AAward	+11.4K sh	—	—	11,352
2018-09-13	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	VP, Chief Financial Officer	AAward	+700K sh	—	—	700,000
2015-12-14	PLXProtalix BioTherapeutics, Inc.P Purchase	VP, Chief Financial Officer	PPurchase	+10K sh	$0.78	+$7,800	10,000
2015-03-23	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	VP, Chief Financial Officer	AAward	+250K sh	—	—	250,000
2012-07-16	PLXProtalix BioTherapeutics, Inc.A Award	VP, Chief Financial Officer	AAward	+185K sh	—	—	185,000
2012-05-02	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	+76K sh	$0.97	+$73.8K	75,964
2012-05-02	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	−50K sh	—	—	0
2012-05-02	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	−76K sh	—	—	0
2012-05-02	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−126K sh	$7.13	−$898K	0
2012-05-02	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	+50K sh	$2.65	+$133K	125,964
2010-10-07	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	+77.8K sh	$0.97	+$75.6K	0
2010-10-07	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−70K sh	$9.67	−$677K	0
2010-10-07	PLXProtalix BioTherapeutics, Inc.F Tax Payment	VP, Chief Financial Officer	FTax Payment	−7,769 sh	$9.73	−$75.6K	0
2010-10-07	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	−77.8K sh	—	—	75,964
2010-09-07	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−31.5K sh	$8.16	−$257K	0
2010-09-07	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	+70K sh	$0.97	+$68K	0
2010-09-07	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	−70K sh	—	—	153,733
2010-09-03	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−38.5K sh	$8.00	−$308K	0
2010-02-25	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	VP, Chief Financial Officer	AAward	+130K sh	—	—	130,000
2009-10-16	PLXProtalix BioTherapeutics, Inc.F Tax Payment	VP, Chief Financial Officer	FTax Payment	−17.7K sh	$9.21	−$163K	0
2009-10-16	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−40.3K sh	$9.35	−$377K	0
2009-10-16	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	−168K sh	—	—	223,733
2009-10-16	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	+168K sh	$0.97	+$163K	0
2009-10-15	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−110K sh	$9.50	−$1.04M	0
2009-07-07	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	+62.2K sh	$0.97	+$60.5K	0
2009-07-07	PLXProtalix BioTherapeutics, Inc.F Tax Payment	VP, Chief Financial Officer	FTax Payment	−12.2K sh	$4.95	−$60.5K	0
2009-07-07	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	−62.2K sh	—	—	391,431
2009-07-07	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−10K sh	$5.01	−$50.1K	0
2009-07-06	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−40K sh	$5.13	−$205K	0
2009-05-18	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−30K sh	$4.00	−$120K	0
2009-05-18	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	+40.3K sh	—	—	453,648
2009-05-18	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	+40.3K sh	$0.97	+$39.2K	40,348
2009-05-18	PLXProtalix BioTherapeutics, Inc.F Tax Payment	VP, Chief Financial Officer	FTax Payment	−10.3K sh	$3.79	−$39.2K	30,000
2009-03-13	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	+39.8K sh	$0.97	+$38.7K	0
2009-03-13	PLXProtalix BioTherapeutics, Inc.F Tax Payment	VP, Chief Financial Officer	FTax Payment	−17.9K sh	$2.16	−$38.7K	0
2009-03-13	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−7,500 sh	$2.23	−$16.7K	0
2009-03-13	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	VP, Chief Financial Officer	MExercise/Conversion	−39.8K sh	—	—	493,996
2009-03-12	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−32.2K sh	$2.22	−$71.6K	0
2009-03-11	PLXProtalix BioTherapeutics, Inc.S Sale	VP, Chief Financial Officer	SSale	−8,849 sh	$2.30	−$20.4K	0
2009-02-25	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	VP, Chief Financial Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Jan 234
Maimon Yossi0001213900-23-004543
SEC(opens sec.gov)
May 164
Maimon Yossi0000899243-22-018135
SEC(opens sec.gov)
Jan 54
Maimon Yossi0000899243-22-000877
SEC(opens sec.gov)
Jan 64
Maimon Yossi0000899243-21-000681
SEC(opens sec.gov)
May 114
Maimon Yossi0000899243-20-012600
SEC(opens sec.gov)
Sep 144
Maimon Yossi0001144204-18-049524
SEC(opens sec.gov)
Dec 154
Protalix BioTherapeutics, Inc.0001144204-15-070834
SEC(opens sec.gov)
May 74
Protalix BioTherapeutics, Inc.0001144204-15-028488
SEC(opens sec.gov)
Jul 184
Maimon Yossi0001144204-12-039998
SEC(opens sec.gov)
May 44
Maimon Yossi0001144204-12-026352
SEC(opens sec.gov)
Oct 84
Maimon Yossi0001209191-10-049835
SEC(opens sec.gov)

Companies

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455

CARMIEL, L3, 20100